-
Most Recent

Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Why Is Gamida Cell (GMDA) Stock Up 48% Today?
Gamida Cell (GMDA) stock is taking off on Tuesday after getting an update from the FDA concerning the company's cell therapy Omisirge.
Why Is ContraFect (CFRX) Stock Down 14% Today?
ContraFect (CFRX) stock is dropping on Tuesday after the company revealed a notice from the Nasdaq and underwent a rally yesterday.
Why Is Bellus Health (BLU) Stock Up 98% Today?
Bellus Health (BLU) stock is taking off on Tuesday after the company announced a $2 billion acquisition deal with GSK (GSK).
Why Is Windtree Therapeutics (WINT) Stock Up 190% Today?
Today, some intriguing patent-related news has shares of Windtree Therapeutics and WINT stock surging, up more than 180%.
Moderna (MRNA) Stock Sinks Despite Positive Cancer Vaccine Update
MRNA stock is sinking this morning despite Moderna releasing positive Phase 2b data on its mRNA cancer vaccine yesterday.
Why Is Marpai (MRAI) Stock Down 40% Today?
Marpai (MRAI) stock is taking a beating on Monday after the company announced a proposed public offering for its shares.
Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?
Prometheus Biosciences (RXDX) stock is on the rise Monday after the company revealed a $10.8 billion acquisition deal with Merck (MRK).
3 Stocks to Buy That Could Be the Next Biotech Breakthrough
Biotech stocks are highly speculative, but it's possible to choose ones with excellent risk-reward ratios.